Columbia Sportswear Company (COLM) Guidance & Earnings Results

On 2026-07-30 Columbia Sportswear Company raised guidance: "FY26 gross margin raised to 52.1-52.3% from 50.3-50.5%; FY26 operating income raised to $290-325M from $230-262M; FY26 diluted EPS raised to $4.45-4.90 from $3.55-4.00; FY26 net sales unchanged $3.43-3.50B; FY26 capex…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

COLMColumbia Sportswear CompanyFollow COLM — free

Apparel Manufacturing · Consumer Cyclical

—

Price chart with a free account

Market cap: 3.1B
P/E TTM: 16.0
Dividend yield: 2.0%
52-week: —
Next earnings: 29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
30 Jul 26	Raised	FY26 gross margin raised to 52.1-52.3% from 50.3-50.5%; FY26 operating income raised to $290-325M from $230-262M; FY26 diluted EPS raised to $4.45-4.90 from $3.55-4.00; FY26 net sales unchanged $3.43-3.50B; FY26 capex unchanged $65-75M; Q3 net sales $929-943M; Q3 diluted EPS $1.15-1.35 · full year
30 Apr 26	Raised	EPS midpoint +$0.35; operating income midpoint +$19M; gross margin midpoint +50bps · full year
30 Oct 25	Lowered	FY2025 net sales $3.33-$3.37B (decline 1%-flat); operating income $163-$185M; EPS $2.55-$2.85 · full year

Columbia Sportswear Company — questions

What guidance did Columbia Sportswear Company give?: On 2026-07-30: "FY26 gross margin raised to 52.1-52.3% from 50.3-50.5%; FY26 operating income raised to $290-325M from $230-262M; FY26 diluted EPS raised to $4.45-4.90 from $3.55-4.00; FY26 net sales unchanged $3.43-3.50B; FY26 capex unchanged $65-75M; Q3 net sales $929-943M; Q3 diluted EPS $1.15-1.35"
When does Columbia Sportswear Company report earnings?: Columbia Sportswear Company's next earnings report is expected on 2026-10-29.

Every figure on this page comes from Columbia Sportswear Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.